A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis
Jyoti Thulkar, Alka Kriplani, Nutan Agarwal, Jyoti Thulkar, Alka Kriplani, Nutan Agarwal
Abstract
Objective: To compare the cure rates of oral single dose of metronidazole (2 g), tinidazole (2 g), secnidazole (2 g), and ornidazole (1.5 g) in cases of bacterial vaginosis.
Materials and methods: This was a prospective, comparative, randomized clinical trial on 344 Indian women (86 women in each group) who attended a gynecology outpatient department with complaint of abnormal vaginal discharge or who had abnormal vaginal discharge on Gynecological examination but they did not complaint of it. For diagnosis and cure rate of bacterial vaginosis, Amsel's criteria were used. Statistical analysis was done by Chi-square test of proportions. The cure rate was compared considering metronidazole cure rate as gold standard.
Results: At 1 week, the cure rate of tinidazole and ornidazole was 100% and at 4 weeks, it was 97.7% for both drugs (P<0.001). Secnidazole had cure rate of 80.2% at 4 weeks (P=NS). Metronidazole showed a cure rate of 77.9% at 4 weeks, which is the lowest of all four drugs.
Conclusion: Tinidazole and ornidazole have better cure rate as compared to metronidazole in cases of bacterial vaginosis.
Keywords: Bacterial vaginosis; metronidazole; ornidazole; secnidazole; tinidazole.
Conflict of interest statement
Conflict of Interest: None declared.
Figures
References
- Bhalla P, Chawla R, Garg S, Singh MM, Raina U, Bhalla R, et al. Prevalence of bacterial vaginosis among women in Delhi. Indian J Med Res. 2007;125:167–72.
- Eriksson K, Carisson B, Forsum U, Larsson PG. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol. 2005;85:42–6.
- Larsson PG, Forsum U. Bacterial vaginosis–A disturbed bacterial flora and treatment enigma. APMIS. 2005;113:305–16.
- Mattila J, Mannisto PT, Mantyla R, Nykanen S, Lamminsivu U. Comparative pharmacokinetics of Metronidazole and Tinidazole as influenced by administration route. Antimicrob Agents Chemother. 1983;23:721–5.
- Gillis JC, Wiseman LR. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs. 1996;51:621–38.
- Martin C, Bruguerolle B, Mallet MN, Condomines M, Sastre B, Gouin F. Pharmacokinetics and tissue penetration of a single dose of Ornidazole. Antimicrob Agent Chemother. 1990;34:1921–4.
- Chaijareenont K, Sirimai K, Boriboonhirunsarn D, Kiriwat O. Accuracy of Nugent's score and each Amsel's criteria in the diagnosis of bacterial vaginosis. J Med Assoc Thai. 2004;87:1270–4.
- Kurt O, Girginkardeþler N, Balcioğlu IC, Ozbilgin A, Ok UZ. A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin Microbiol Infect. 2008;14:601–4.
- Baylson FA, Nyirjesy P, Weitz MV. Treatment of recurrent bacterial vaginosis with Tinidazole. Obstet Gynecol. 2004;104:931–2.
- Schindler EM, Thamm H, Ansmann EB, Sarnow E, Schindler AE. Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparision with metronidazole. Fortschr Med. 1991;109:138–40.
- Gillis JC, Wiseman LR. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs. 1996;51:621–38.
- Rosenblatt JE, Edson RS. Symposium on antimicrobial agents. Metronidazole. Mayo Clin Proc. 1987;62:1013–7.
- Erkkola R, Jarvinen H. Single dose of Ornidazole in the treatment of bacterial vaginosis. Ann Chir Gynaecol Suppl. 1987;202:94–6.
- McFarland LV, Elmer GW. Pharmaceutical probiotics for the treatment of Anaerobic and other infections. Anaerobe. 1997;3:73–8.
Source: PubMed